Bio LAB | 01 December 2024 | Analysis
2025 Trends Buoying Boom Phase in APAC
Antibody Drug Conjugates (ADCs) in Stoplight ADCs, touted as ‘magic bullets’ for targeted c...Read more
Artificial Intelligence | 01 December 2024 | Opinion
Sustainability continues to gain significant attention in 2025
From the emergence of recombinant DNA technology in the 1970s to advancements in monoclonal antibodies and lar...Read more
Vietnam | 01 December 2024 | Analysis
How Vietnam is Leveraging AI to Reshape Healthcare
Access Partnership, the world’s leading tech advisory firm, recently presented an economic impact report...Read more
Singapore | 29 November 2024 | Opinion
Unlocking the Innovation Potential in Singapore’s Life Sciences Ecosystem
In October 2023, Johnson & Johnson announced a collaboration with the Singapore Economic Development Board...Read more
BioTech | 01 December 2024 | Opinion
AI’s Future Integration into Clinical Practice: In the coming years, AI will become seamlessly integrate...Read more
Singapore | 18 October 2024 | News
BioSpectrum Asia sets the tone for Excellence Awards 2024 at Singapore on 6 December
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in...Read more
Taiwan | 03 December 2024 | News
US-Taiwan partnership to advance manufacturing of Sjögren's Syndrome drug
Ainos, Inc., an innovative healthcare company focused on advanced artificial intelligence (AI)-driven point-of...Read more
North America | 13 November 2024 | News
US-based ICU Medical, Inc., a worldwide leader in the development, manufacture and sale of innovative med...Read more
China | 26 September 2024 | News
Nuance Pharma expands distribution of nasal spray Bentrio in East and South East Asia
China-based Nuance Pharma has agreed with Altamira Medica, an associate company of Altamira Therapeutics ...Read more
China | 03 December 2024 | News
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved t...Read more
Singapore | 13 November 2024 | News
Scientists in Singapore use microcellular drones to deliver lung cancer-killing drugs
A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and ...Read more
Australia | 29 October 2024 | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density micro...Read more
Indonesia | 27 November 2024 | News
India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
SS Innovations, the developer of India’s first indigenous surgical robotic system, dedicated to making a...Read more
Singapore | 19 November 2024 | News
Singapore's SERI and Carl Zeiss invest SG$20 M for driving innovation in ophthalmic surgery
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG, one of the world's leading medical tech...Read more
Europe | 13 November 2024 | News
Korea's Lunit partners with VIDI group to deliver AI-powered mammography in France
South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagn...Read more
Europe | 12 November 2024 | News
Lonza expands Bioconjugation capabilities with two additional manufacturing suites in Switzerland
Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets...Read more
China | 29 October 2024 | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (C...Read more
Korea | 01 October 2024 | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production
US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announ...Read more
2025 Trends Buoying Boom Phase in APAC
Like many industries, life sciences, too, faced numerous challenges in 2024, such as a slowing economy, and geopolitical conflicts. Despite these headwinds, the sector has shown remarkable resilience, with strong prospects for recovery and growth. Significant investments are being directed toward research and development in key areas such as Antibody Drug Conjugates (ADCs), Cell and Gene Therapies, Artificial Intelligence (AI) and Contract Development and Manufacturing Organisations (CDMOs) and many more. These fields have been major drivers of growth this year and offer promising opportunities. It’s that time of year again when we interact with leaders from major market segments of the industry. These leaders provide their insights into what the coming year is likely to hold for their respective fields. Lets look into a few trends from life sciences that are expected to
make a significant splash in 2025.
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
